Benefit of hepatitis C virus core antigen assay in prediction of therapeutic response to interferon and ribavirin combination therapy
about
Comparison of serum hepatitis C virus (HCV) RNA and core antigen levels in patients coinfected with human immunodeficiency virus and HCV and treated with interferon plus ribavirin.CS-SELEX Generates High-Affinity ssDNA Aptamers as Molecular Probes for Hepatitis C Virus Envelope Glycoprotein E2Evaluation of Hepatitis C Virus Core Antigen Assays in Detecting Recombinant Viral Antigens of Various GenotypesOn-treatment predictions of success in peg-interferon/ribavirin treatment using a novel formulaAnalytical Performance Characteristics and Clinical Utility of a Novel Assay for Total Hepatitis C Virus Core Antigen QuantificationHCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes.A higher correlation of HCV core antigen with CD4+ T cell counts compared with HCV RNA in HCV/HIV-1 coinfected patientsStrong correlation between liver and serum levels of hepatitis C virus core antigen and RNA in chronically infected patientsJapanese reference panel of blood specimens for evaluation of hepatitis C virus RNA and core antigen quantitative assaysSASLT practice guidelines: management of hepatitis C virus infection.Hepatitis C core Ag and its clinical applicability: potential advantages and disadvantages for diagnosis and follow-up?New automated hepatitis C virus (HCV) core antigen assay as an alternative to real-time PCR for HCV RNA quantification.Hepatitis C virus window-phase infections: closing the window on hepatitis C virus.
P2860
Q27473034-632B5550-59E3-47CA-AE47-F4D288224157Q27490421-5D2EBF9B-A7AC-4DB1-B1A0-73788A304134Q27490457-6B89E2A9-2C9D-4465-AA02-6085F19967D6Q27490760-FEB2F600-4D5D-4B9E-A46E-1D84CFFBBC77Q27491329-64BF693B-64CB-4285-89DE-7C90E77FE98EQ33645428-9C86A98F-CF4E-4C34-B772-454680F93660Q33999798-92BA9A82-8221-47BB-82D6-EB3FCB6F310DQ35689119-D4808B71-E565-4619-A6C6-D4E8D866E91CQ36022842-8A79CD90-3705-45D9-B2B8-C1748BB36A87Q37019765-636B2394-BC52-43F5-86F9-6EA5FEBC8CAFQ37961619-F618DD41-D15A-4C77-8B1F-DB0765F8105DQ41015616-D93E9E68-464A-485A-B721-3B2C8B9D32D3Q43047661-0023D6E5-5AD9-41F4-966A-DB39F1F8335F
P2860
Benefit of hepatitis C virus core antigen assay in prediction of therapeutic response to interferon and ribavirin combination therapy
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Benefit of hepatitis C virus c ...... ribavirin combination therapy
@ast
Benefit of hepatitis C virus c ...... ribavirin combination therapy
@en
type
label
Benefit of hepatitis C virus c ...... ribavirin combination therapy
@ast
Benefit of hepatitis C virus c ...... ribavirin combination therapy
@en
prefLabel
Benefit of hepatitis C virus c ...... ribavirin combination therapy
@ast
Benefit of hepatitis C virus c ...... ribavirin combination therapy
@en
P2093
P2860
P1476
Benefit of hepatitis C virus c ...... ribavirin combination therapy
@en
P2093
Hidetsugu Saito
Hiromasa Ishii
Kazuhiro Atsukawa
Makiko Higashimoto
Masahiko Takahashi
P2860
P304
P356
10.1128/JCM.43.1.186-191.2005
P407
P577
2005-01-01T00:00:00Z